keyword
https://read.qxmd.com/read/38731421/the-benzoylpiperidine-fragment-as-a-privileged-structure-in-medicinal-chemistry-a-comprehensive-review
#21
REVIEW
Giulia Bononi, Chiara Lonzi, Tiziano Tuccinardi, Filippo Minutolo, Carlotta Granchi
The phenyl(piperidin-4-yl)methanone fragment (here referred to as the benzoylpiperidine fragment) is a privileged structure in the development of new drugs considering its presence in many bioactive small molecules with both therapeutic (such as anti-cancer, anti-psychotic, anti-thrombotic, anti-arrhythmic, anti-tubercular, anti-parasitic, anti-diabetic, and neuroprotective agents) and diagnostic properties. The benzoylpiperidine fragment is metabolically stable, and it is also considered a potential bioisostere of the piperazine ring, thus making it a feasible and reliable chemical frame to be exploited in drug design...
April 23, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38730542/development-and-evaluation-of-chemometric-models-for-the-estimation-of-sumatriptan-in-the-presence-of-naproxen-and-a-degradation-product-using-uv-spectrophotometry
#22
JOURNAL ARTICLE
Adel M Michael, Hayam M Lotfy, Mamdouh R Rezk, Christine K Nessim
BACKGROUND: Chemometrics is a discipline that allows the spectral resolution of drugs in a pharmaceutical formulation along with degradation product and it is as an alternative to chromatographic methods. OBJECTIVE: Sumatriptan (SUM) is co-formulated with naproxen (NAP) and used in acute migraine attacks. SUM which has physiological importance has not been subjected to any stability-indicating chemometric approaches yet so there is a need for accurate and safe method for the assay of the cited drug in their preparation...
May 10, 2024: Journal of AOAC International
https://read.qxmd.com/read/38730324/discovery-of-llc355-as-an-autophagy-tethering-compound-for-the-degradation-of-discoidin-domain-receptor-1
#23
JOURNAL ARTICLE
Lianchao Liu, Lijie Zhao, Lujun Yang, Minxue Chai, Zhengyong Liu, Nan Ma, Yongxing Wang, Qinxue Wu, Jing Guo, Fengtao Zhou, Weixue Huang, Xiaomei Ren, Jian Wang, Ming Ding, Zhen Wang, Ke Ding
Discoidin domain receptor 1 (DDR1) is a potential target for cancer drug discovery. Although several DDR1 kinase inhibitors have been developed, recent studies have revealed the critical roles of the noncatalytic functions of DDR1 in tumor progression, metastasis, and immune exclusion. Degradation of DDR1 presents an opportunity to block its noncatalytic functions. Here, we report the discovery of the DDR1 degrader LLC355 by employing autophagosome-tethering compound technology. Compound LLC355 efficiently degraded DDR1 protein with a DC50 value of 150...
May 10, 2024: Journal of Medicinal Chemistry
https://read.qxmd.com/read/38730259/new-route-to-target-ras
#24
M Teresa Villanueva
No abstract text is available yet for this article.
May 10, 2024: Nature Reviews. Drug Discovery
https://read.qxmd.com/read/38729623/discovery-of-nelutroctiv-ck-136-a-selective-cardiac-troponin-activator-for-the-treatment-of-cardiovascular-diseases-associated-with-reduced-cardiac-contractility
#25
JOURNAL ARTICLE
Antonio Romero, Luke Ashcraft, Aroop Chandra, Vincent DiMassa, Peadar Cremin, Scott E Collibee, Chihyuan Chuang, James Hartman, Darren T Hwee, David St Jean, Justin Malinowski, Mikkel DeBenedetto, David Moebius, Joshua Payette, Richard Vargas, John Yeoman, Alykhan Motani, Jeffrey Reagan, Fady I Malik, Bradley P Morgan
Cardiac myosin activation has been shown to be a viable approach for the treatment of heart failure with reduced ejection fraction. Here, we report the discovery of nelutroctiv ( CK-136 ), a selective cardiac troponin activator intended for patients with cardiovascular conditions where cardiac contractility is reduced. Discovery of nelutroctiv began with a high-throughput screen that identified compound 1R , a muscle selective cardiac sarcomere activator devoid of phosphodiesterase-3 activity. Optimization of druglike properties for 1R led to the replacement of the sulfonamide and aniline substituents which resulted in improved pharmacokinetic (PK) profiles and a reduced potential for human drug-drug interactions...
May 10, 2024: Journal of Medicinal Chemistry
https://read.qxmd.com/read/38729448/mical-l2-as-an-estrogen-responsive-gene-is-involved-in-er-positive-breast-cancer-cell-progression-and-tamoxifen-sensitivity-via-the-akt-mtor-pathway
#26
JOURNAL ARTICLE
Pushuai Wen, Jing Li, Zihao Wen, Xiaoyan Guo, Guoqun Ma, Shuzhen Hu, Jiamei Xu, Hongli Zhao, Ruixin Li, Ying Liu, Yu Wang, Jing Gao
Endocrine treatment, particularly tamoxifen, has shown significant improvement in the prognosis of patients with estrogen receptor-positive (ER-positive) breast cancer. However, the clinical utility of this treatment is often hindered by the development of endocrine resistance. Therefore, a comprehensive understanding of the underlying mechanisms driving ER-positive breast cancer carcinogenesis and endocrine resistance is crucial to overcome this clinical challenge. In this study, we investigated the expression of MICAL-L2 in ER-positive breast cancer and its impact on patient prognosis...
May 8, 2024: Biochemical Pharmacology
https://read.qxmd.com/read/38729447/exploring-the-role-of-myeloperoxidase-in-the-atherosclerotic-process-in-hypoxic-mice-based-on-the-mapk-signaling-pathway
#27
JOURNAL ARTICLE
Jingxuan Zhang, Ying Han, Ruhan Jia, Qinfang Zhu, Xiaozhou Wang, Meiheng Liu, Wei Zhang
Atherosclerosis (AS) is the common pathophysiological basis of various cardiovascular diseases and the leading cause of death from cardiovascular disease worldwide. When the body is in a hypoxic environment, enhanced oxidative stress and significant accumulation of reactive oxygen species (ROS) in tissue cells exacerbate the inflammatory response, resulting in increased release of myeloperoxidase (MPO), catalyzing the formation of large quantities of hypochlorous acid (HOCl), further oxidative modification of low-density lipoprotein (LDL), and exacerbating the formation and progression of atherosclerotic plaques...
May 8, 2024: Biochemical Pharmacology
https://read.qxmd.com/read/38729446/relaxin-as-a-treatment-for-musculoskeletal-fibrosis-what-we-know-and-future-directions
#28
REVIEW
Atousa Nourmahnad, Mohammad Javad Shariyate, Mohamad Khak, Mark W Grinstaff, Ara Nazarian, Edward K Rodriguez
Fibrotic changes in musculoskeletal diseases arise from the abnormal buildup of fibrotic tissue around the joints, leading to limited mobility, compromised joint function, and diminished quality of life. Relaxin (RLX) attenuates fibrosis by accelerating collagen degradation and inhibiting excessive extracellular matrix (ECM) production. Further, RLX disrupts myofibroblast activation by modulating the TGF-β/Smads signaling pathways, which reduces connective tissue fibrosis. However, the mechanisms and effects of RLX in musculoskeletal pathologies are emerging as increasing research focuses on relaxin's impact on skin, ligaments, tendons, cartilage, joint capsules, connective tissues, and muscles...
May 8, 2024: Biochemical Pharmacology
https://read.qxmd.com/read/38729441/application-of-in-vitro-bioassays-to-monitor-pharmaceuticals-in-water-a-synthesis-of-chronological-analysis-mode-of-action-and-practical-insights
#29
REVIEW
Rameesha Tanveer, Peta A Neale, Steven D Melvin, Frederic D L Leusch
Pharmaceutical compounds in wastewater have emerged as a significant concern for the aquatic environment. The use of in vitro bioassays represents a sustainable and cost-effective approach for assessing the potential toxicological risks of these biologically active compounds in wastewater and aligns with ethical considerations in research. It facilitates high-throughput analysis, captures mixture effects, integrates impacts of both known and unknown chemicals, and reduces reliance on animal testing. The core aim of the current review was to explore the practical application of in vitro bioassays in evaluating the environmental impacts of pharmaceuticals in wastewater...
May 8, 2024: Chemosphere
https://read.qxmd.com/read/38729318/synthesis-of-2-2-dimethyl-chroman-based-stereochemically-flexible-and-constrained-anti-breast-cancer-agents
#30
JOURNAL ARTICLE
Kripa Shanker Nainawat, Kratika Gupta, Neelam Gupta, Romila Singh, Divya Mishra, Abhishek Nirwan, Meenakshi Verma, Amrita Singh, Prema G Vasudev, Feroz Khan, Durga Prasad Mishra, Atul Gupta
Receptors are proteinous macromolecules which remain in the apo form under normal/unliganded conditions. As the ligand approaches, there are specific stereo-chemical changes in the apo form of the receptor as per the stereochemistry of a ligand. Accordingly, a series of substituted dimethyl-chroman-based stereochemically flexible and constrained Tamoxifen analogs were synthesized as anti-breast cancer agents. The synthesized compounds 19a-e, 20a-e, 21, and 22a-e, showed significant antiproliferative activity against estrogen receptor-positive (ER+ , MCF-7) and negative (ER- , MDA MB-231) cells within IC50 value 8...
May 8, 2024: Bioorganic & Medicinal Chemistry Letters
https://read.qxmd.com/read/38729317/discovery-of-a-dcaf11-dependent-cyanoacrylamide-containing-covalent-degrader-of-bet-proteins
#31
JOURNAL ARTICLE
Gary Tin, Marko Cigler, Matthias Hinterndorfer, Kevin D Dong, Hana Imrichova, Steven P Gygi, Georg E Winter
Targeted protein degradation is mediated by small molecules that induce or stabilize protein-protein interactions between targets and the ubiquitin-proteasome machinery. Currently, there remains a need to expand the repertoire of viable E3 ligases available for hijacking. Notably, covalent chemistry has been employed to engage a handful of E3 ligases, including DCAF11. Here, we disclose a covalent PROTAC that enables DCAF11-dependent degradation, featuring a cyanoacrylamide warhead. Our findings underscore DCAF11 as an interesting candidate with a capacity to accommodate diverse electrophilic chemistries compatible with targeted protein degradation...
May 8, 2024: Bioorganic & Medicinal Chemistry Letters
https://read.qxmd.com/read/38729224/long-acting-intramuscular-injections-of-elq-331-an-antimalarial-agent
#32
JOURNAL ARTICLE
Dipu Karunakaran, Shravan K Mutyam, Melody Fu, Jiaming Chen, Kim Hue Nicky Pham, Sovitj Pou, Rolf W Winter, Aaron Nilsen, Rozalia A Dodean, Martin J Smilkstein, Michael K Riscoe, Gita Shankar
The overarching premise of this investigation is that injectable, long-acting antimalarial medication would encourage adherence to a dosage regimen for populations at risk of contracting the disease. To advance support for this goal, we have developed oil-based formulations of ELQ-331 (a prodrug of ELQ-300) that perform as long-acting, injectable chemoprophylactics with drug loading as high as 160 mg/ml of ELQ-331. In a pharmacokinetic study performed with rats, a single intramuscular injection of 12.14 mg/kg maintained higher plasma levels than the previously established minimum fully protective plasma concentration (33...
May 8, 2024: European Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38729089/ultra-high-performance-liquid-chromatography-tandem-mass-spectrometry-assay-for-simultaneous-determination-of-22-marker-compounds-in-traditional-herbal-medicine-ojeoksan
#33
JOURNAL ARTICLE
Hee-Seo Kim, Seung-Hoon Baek
Traditional herbal medicines (THMs) have long been in use worldwide and are considered safe for use as tonics or complementary treatments for many diseases. Advanced quality control methods for THMs are required in the regulatory framework of modern medicines. In this study, an ultra-high performance liquid chromatography-tandem mass spectrometry assay was established for the simultaneous determination of 22 marker compounds in Ojeoksan (OJS), which is composed of 15 herbal substances. All marker compounds were analyzed within 20 min and successfully identified via scheduled multiple reaction monitoring...
May 1, 2024: Journal of Pharmaceutical and Biomedical Analysis
https://read.qxmd.com/read/38728951/technical-and-health-governance-aspects-of-the-external-quality-assessment-system-for-classical-and-new-psychoactive-substances-analysis-testing-in-blood
#34
JOURNAL ARTICLE
Francesca Di Gaudio, Vita Giaccone, Annamaria Cucina, Sergio Indelicato, Maria Raso, Giuseppina Brunacci, Anna Lundari, Maria Concetta Rotolo, Francesco Busardò, Mario La Rocca
New psychoactive substances (NPS) are uncontrolled analogues of existing drugs or newly synthesized chemicals that exhibit psychopharmacological effects. Due to their diverse nature, composition, and increasing prevalence, they present significant challenges to the healthcare system and drug control policies. In response, healthcare system laboratories have developed analytical methods to detect NPS in biological samples. As a Regional Reference Centre, the Sicilian CRQ Laboratory (Regional Laboratory for Quality Control) developed and conducted an External Quality Assessment (EQA) study to assess, in collaboration with the Istituto Superiore di Sanità (ISS), the ability of different Italian laboratories to identify NPS and traditional drugs of abuse (DOA) in biological matrices...
April 24, 2024: Journal of Pharmaceutical and Biomedical Analysis
https://read.qxmd.com/read/38728950/magnetic-stirring-enhanced-mechanical-amorphous-dispersion-extraction-for-the-hydrophobic-phytochemical-constituents-using-an-aqueous-solution-from-a-medicinal-plant
#35
JOURNAL ARTICLE
Huang-Fei Jin, Qian-Xue Shen, Ying Shi, Fang-Ming Liu, Bin Wang, Jun Cao, Li-Hong Ye
A method involving chitosan-assisted magnetic-stirring-enhanced mechanical amorphous dispersion extraction was developed and utilized to extract hydrophobic anthraquinones from Rhei Radix et Rhizoma prior to ultrahigh performance liquid chromatography analysis. Incorporating natural chitosan as a dispersant facilitated the extraction of hydrophobic anthraquinones using purified water, considerably enhancing the eco-friendliness of the extraction methodology. To optimize extraction efficiency, an extensive evaluation of the crucial parameters influencing rhubarb yield was conducted...
May 1, 2024: Journal of Pharmaceutical and Biomedical Analysis
https://read.qxmd.com/read/38728918/systematic-review-on-fingerprinting-development-to-determine-adulteration-of-chinese-herbal-medicines
#36
JOURNAL ARTICLE
Yongdi Luo, Hongbo Yang, Guangcan Tao
BACKGROUND: It has been a current research hospots using fingerprinting technology for quality control of Chinese herbal medicines (CHMs), which provides a scientific basis for establishment of overall quality control in accordance with the characteristics of CHMs. The fingerprinting technology for CHMs is diverse, and the research field covers many disciplines, such as analytical chemistry, pharmacology, pharmaceutics, biochemistry, and molecular biology. PURPOSE: To effectively understand the key areas and future directions of research regarding the fingerprint and adulteration of CHMs...
April 22, 2024: Phytomedicine
https://read.qxmd.com/read/38728869/supramolecular-prodrug-of-sn38-based-on-endogenous-albumin-and-sn38-prodrug-modified-with-semaglutide-side-chain-to-improve-the-tumor-distribution
#37
JOURNAL ARTICLE
Qingyu Wei, Yanyan Wu, Xing Jiang, Wei Lu, Shiyuan Liu, Jiahui Yu
To improve the biodistribution of the drug in the tumor, a supramolecular prodrug of SN38 was fabricated in situ between endogenous albumin and SN38 prodrug modified with semaglutide side chain. Firstly, SN38 was conjugated with semaglutide side chain and octadecanedioic acid via glycine linkers to obtain SI-Gly-SN38 and OA-Gly-SN38 prodrugs, respectively. Both SI-Gly-SN38 and OA-Gly-SN38 exhibited excellent stability in PBS for over 24 h. Due to the strong binding affinity of the semaglutide side chain with albumin, the plasma half-life of SI-Gly-SN38 was 2...
May 7, 2024: Bioorganic & Medicinal Chemistry
https://read.qxmd.com/read/38728868/analogues-of-the-pan-selectin-antagonist-rivipansel-gmi-1070
#38
JOURNAL ARTICLE
Beatrice Wagner, Martin Smieško, Roman P Jakob, Tobias Mühlethaler, Jonathan Cramer, Tim Maier, Said Rabbani, Oliver Schwardt, Beat Ernst
The selectin family consisting of E-, P- and L-selectin plays dominant roles in atherosclerosis, ischemia-reperfusion injury, inflammatory diseases, and metastatic spreading of some cancers. An early goal in selectin-targeted drug discovery campaigns was to identify ligands binding to all three selectins, so-called pan-selectin antagonists. The physiological epitope, tetrasaccharide sialyl Lewisx (sLex , 1) binds to all selectins, albeit with very different affinities. Whereas P- and L-selectin require additional interactions contributed by sulfate groups for high binding affinity, E-selectin can functionally bind sLex -modified glycolipids and glycoproteins...
April 30, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38728867/recent-advances-and-future-directions-on-small-molecule-vegfr-inhibitors-in-oncological-conditions
#39
REVIEW
Amandeep Thakur, Mandeep Rana, Anshul Mishra, Charanjit Kaur, Chun-Hsu Pan, Kunal Nepali
"A journey of mixed emotions" is a quote that best describes the progress chart of vascular endothelial growth factor receptor (VEGFR) inhibitors as cancer therapeutics in the last decade. Exhilarated with the Food and Drug Administration (FDA) approvals of numerous VEGFR inhibitors coupled with the annoyance of encountering the complications associated with their use, drug discovery enthusiasts are on their toes with an unswerving determination to enhance the rate of translation of VEGFR inhibitors from preclinical to clinical stage...
May 6, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38728572/ligandability-assessment-of-il-1%C3%AE-by-integrated-hit-identification-approaches
#40
JOURNAL ARTICLE
Anna Vulpetti, Jean-Michel Rondeau, Marie-Hélène Bellance, Jutta Blank, Ralf Boesch, Andreas Boettcher, Frédéric Bornancin, Sylvia Buhr, Lauren E Connor, Christoph E Dumelin, Oliver Esser, Michael Hediger, Samuel Hintermann, Ulrich Hommel, Elke Koch, Guillaume Lapointe, Lukas Leder, Sylvie Lehmann, Philipp Lehr, Peter Meier, Lionel Muller, Daniela Ostermeier, Paul Ramage, Sihame Schiebel-Haddad, Alexander Baxter Smith, Aleksandar Stojanovic, Juraj Velcicky, Rina Yamamoto, Konstanze Hurth
Human interleukin-1β (IL-1β) is a pro-inflammatory cytokine that plays a critical role in the regulation of the immune response and the development of various inflammatory diseases. In this publication, we disclose our efforts toward the discovery of IL-1β binders that interfere with IL-1β signaling. To this end, several technologies were used in parallel, including fragment-based screening (FBS), DNA-encoded library (DEL) technology, peptide discovery platform (PDP), and virtual screening...
May 10, 2024: Journal of Medicinal Chemistry
keyword
keyword
44755
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.